Last reviewed · How we verify
NCT01317966: Incritop
A Multicentre Investigation of Recombinant Human Interleukin-11 (rhIL-11) Combination Low-dose Rituximab in Management of Steroid-Resistant/Relapsed Immune Thrombocytopenia (ITP)
trial testing rhIL-11 in Purpura, Thrombocytopenic, Idiopathic. Withdrawn.
1 December 2011
Quick facts
| Lead sponsor | Ming Hou |
|---|---|
| Status | Withdrawn |
| Study type | OBSERVATIONAL |
| Start date | 1 March 2011 |
| Primary completion | 1 December 2011 |
| Estimated completion | 1 March 2012 |
| Sites | 1 location across China |
Drugs / interventions tested
- rhIL-11 — full drug profile →
Conditions studied
- Purpura, Thrombocytopenic, Idiopathic — all drugs for Purpura, Thrombocytopenic, Idiopathic →
Sponsor
Ming Hou — full company profile →
Who can join
Adults 16 to 75, any sex, with Purpura, Thrombocytopenic, Idiopathic. Patients with the condition only — healthy volunteers not accepted.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
Evaluation of platelet response (Complete Response)
Time frame: The time frame is up to 14 days per subject
CR. A complete response (CR) was defined as a sustained (≥ 4 months) platelet count ≥ 100×109/L without recurrence of thrombocytopenia
Sponsor's own description
The purpose of this study is to determine whether Recombinant Human Interleukin-11 (rhIL-11) Combination Low-dose Rituximab prednisone are effective and safe in the management of Steroid-Resistant/Relapsed Immune Thrombocytopenia (ITP).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT01317966
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of rhIL-11
Trials testing the same drug.
- NCT03823079 — Comparison of Interleukin-11 and rhTPO for Recurrent Colorectal Cancer Patients With Thrombocytopenia · Phase 2 · unknown
Other Ming Hou trials
Trials by the same sponsor.
- NCT05095896 — The Serum Lipid Profiles in ITP: a Retrospective Study · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01317966 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ming Hou
- Last refreshed: 18 April 2016
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01317966.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing